Progyny, Inc.
Progyny, Inc. (NASDAQ: PROG) is a global leader in women's health and family building solutions. The company operates through a comprehensive platform designed to address the continuum of women's health from fertility and family building through pregnancy, postpartum, menopause, and parent and child wellbeing.… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Progyny, Inc. does
In the company’s own words
Progyny, Inc. (NASDAQ: PROG) is a global leader in women's health and family building solutions. The company operates through a comprehensive platform designed to address the continuum of women's health from fertility and family building through pregnancy, postpartum, menopause, and parent and child wellbeing. Progyny's mission is to empower healthier, supported journeys through transformative fertility, family building and women's health benefits.
The company's core offering is its fertility benefits solution, which features the proprietary Smart Cycle approach—an innovative benefits design that provides equitable access to comprehensive fertility treatment bundles. Progyny also offers Progyny Rx, an integrated pharmacy benefits solution that manages medications needed during treatment. Additional solutions include pregnancy and postpartum support, menopause and midlife services, benefit and leave navigation, parent and child wellbeing programs, and assistance service reimbursement programs for adoption and surrogacy. Progyny Global extends these offerings internationally with country-specific compliance frameworks.
As of December 31, 2025, Progyny served over 590 employers across more than 40 industries, providing coverage to approximately 7.2 million employees and their covered dependents. The company maintains a selective network of over 1,100 fertility specialists practicing at more than 690 provider clinic locations throughout the United States, including 45 of the top 50 fertility practice groups by volume. The company employs 856 people, with 835 full-time employees.
Progyny's value proposition centers on delivering measurable financial value to employers through superior clinical outcomes and cost management, meaningful support to members through comprehensive coverage and high-touch concierge services, and collaborative value to providers through comprehensive member benefits and data sharing. The company's data collection process directly captures clinical outcomes from fertility providers, enabling active network management and continuous improvement of clinical protocols.
The company's website is www.progyny.com. Progyny operates primarily in the self-insured employer market and Taft-Hartley labor populations, with an addressable market estimated at approximately 106 million potential covered lives in the United States.
Company details
- Sector
- Healthcare
- Industry
- Health Services
- Headquarters
- NEW YORK, NY
- Fiscal year end
- December
- CIK
- 1551306
- SIC
- 8090
Financial performance, year by year
Fiscal 2019–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Progyny, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Progyny, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Progyny, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Progyny, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Progyny, Inc.'s last four quarterly filings that the numbers alone won't show?”